Home LiteratureArticle Details
PMID: 24717062 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease.

Respiratory research ·Vol. 15 ·2014-04-10 ·Pages 40

Hasegawa K, Tsugawa Y, Tsai CL, Brown DF, Camargo CA

Abstract

Little is known about patients who frequently visit the emergency department (ED) for acute exacerbation of chronic obstructive pulmonary disease (AECOPD). We aimed to quantify the proportion and characteristics of patients with frequent ED visits for AECOPD and associated healthcare utilization. We conducted a retrospective cohort study of adults aged ≥40 years with at least one ED visit for AECOPD between 2010 and 2011, derived from population-based all-payer data of State ED and Inpatient Databases for two large and diverse states: California and Florida. Outcome measures were frequency of ED visits for AECOPD, 30-day ED revisits, subsequent hospitalizations, near-fatal events (AECOPD involving mechanical ventilation), and charges for both ED and inpatient services (available only for Florida) during the year after the first ED visit. The analytic cohort comprised 98,280 unique patients with 154,736 ED visits for AECOPD. During the 1-year period, 29.4% (95% CI, 29.1%-29.7%) of the patients had two or more (frequent) visits, accounting for 55.2% (95% CI, 54.9%-55.4%) of all ED visits for AECOPD. In the multivariable model, significant predictors of frequent ED visits were age 55-74 years (vs. 40-54 years), male sex, non-Hispanic white or black race, Medicaid insurance (vs. private), and lower median household income (all P < 0.001). At the visit-level, 12.3% of ED visits for AECOPD were 30-day revisit events (95% CI, 12.1%-12.4%). Additionally, 62.8% of ED visits for AECOPD (95% CI, 62.6%-63.0%) resulted in a hospitalization; patients with frequent ED visits comprised 55.5% (95% CI, 55.2%-55.8%) of all hospitalizations. Furthermore, 7.3% (95% CI, 7.3%-7.5%) of ED visits for AECOPD led to a near-fatal event; patients with frequent ED visits accounted for 64.4% (95% CI, 63.5%-65.3%) of all near-fatal events. Total charges for AECOPD were $1.94 billion (95% CI, $1.90-1.97 billion) in Florida; patients with frequent ED visits accounted for $1.07 billion (95% CI, $1.04-1.09 billion). In this large cohort study, we found that 29% had frequent ED visits for AECOPD and that lower socioeconomic status was significantly associated with a higher frequency of ED visits. Individuals with frequent ED visits for AECOPD accounted for a substantial amount of healthcare utilization and financial burden.

MeSH Terms
Acute Disease Adult Aged Cohort Studies Disease Progression Emergency Service, Hospital/economics,statistics & numerical data Female Humans Male Middle Aged Pulmonary Disease, Chronic Obstructive/economics,epidemiology,therapy Retrospective Studies Socioeconomic Factors United States/epidemiology
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Hasegawa Kohei
Department of Emergency Medicine, Massachusetts General Hospital, 326 Cambridge Street, Suite 410, Boston, MA 02114, USA. [email protected].
Tsugawa Yusuke
Tsai Chu-Lin
Brown David Fm
Camargo Carlos A
References (29)
29 references, click to expand
  1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.
    Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76 PMID: 11316667
  2. Susceptibility to exacerbation in chronic obstructive pulmonary disease.
    N Engl J Med. 2010 Sep 16;363(12):1128-38 PMID: 20843247
  3. Temporal trends in emergency department visits for bronchiolitis in the United States, 2006 to 2010.
    Pediatr Infect Dis J. 2014 Jan;33(1):11-8 PMID: 23934206
  4. COPD surveillance--United States, 1999-2011.
    Chest. 2013 Jul;144(1):284-305 PMID: 23619732
  5. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study.
    Chest. 2011 Sep;140(3):626-633 PMID: 21474571
  6. Prospective multicenter study of relapse following emergency department treatment of COPD exacerbation.
    Chest. 2004 Feb;125(2):473-81 PMID: 14769727
  7. Self-management education for patients with chronic obstructive pulmonary disease.
    Cochrane Database Syst Rev. 2007 Oct 17;(4):CD002990 PMID: 17943778
  8. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.
    Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1418-22 PMID: 9603117
  9. Factors associated with frequency of emergency department visits for chronic obstructive pulmonary disease exacerbation.
    J Gen Intern Med. 2007 Jun;22(6):799-804 PMID: 17410402
  10. Utilization, spending, and price trends for short- and long-acting Beta-agonists and inhaled corticosteroids in the medicaid program, 1991-2010.
    Am Health Drug Benefits. 2011 May;4(3):140-9 PMID: 25126346
  11. Do HMOs reduce preventable hospitalizations for Medicare beneficiaries?
    Med Care Res Rev. 2007 Oct;64(5):544-67 PMID: 17881621
  12. Socioeconomic status and prognosis of COPD in Denmark.
    COPD. 2014 Aug;11(4):431-7 PMID: 24568315
  13. Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease.
    Arch Intern Med. 2010 Oct 11;170(18):1664-70 PMID: 20937926
  14. Temporal trends in hospitalization rates for older adults with chronic obstructive pulmonary disease.
    Am J Med. 2013 Jul;126(7):607-14 PMID: 23688662
  15. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.
    Am J Respir Crit Care Med. 2001 Aug 1;164(3):358-64 PMID: 11500333
  16. Ways of measuring rates of recurrent events.
    BMJ. 1996 Feb 10;312(7027):364-7 PMID: 8611837
  17. Population-based burden of COPD-related visits in the ED: return ED visits, hospital admissions, and comorbidity risks.
    Chest. 2013 Sep;144(3):784-793 PMID: 23579283
  18. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.
    Thorax. 2002 Oct;57(10):847-52 PMID: 12324669
  19. Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic.
    COPD. 2009 Dec;6(6):446-51 PMID: 19938968
  20. Controversies in treatment of chronic obstructive pulmonary disease.
    Lancet. 2011 Sep 10;378(9795):1038-47 PMID: 21907867
  21. Epidemiology of emergency department visits for opioid overdose: a population-based study.
    Mayo Clin Proc. 2014 Apr;89(4):462-71 PMID: 24629443
  22. Potentially avoidable hospitalizations for COPD and pneumonia: the role of physician and practice characteristics.
    Med Care. 2007 Jun;45(6):562-70 PMID: 17515784
  23. Addressing asthma health disparities: a multilevel challenge.
    J Allergy Clin Immunol. 2009 Jun;123(6):1209-17; quiz 1218-9 PMID: 19447484
  24. Appropriate statistical treatment of frequent emergency department visits in health services research.
    Ann Emerg Med. 2007 Mar;49(3):385; author reply 385-6 PMID: 17317518
  25. Influenza vaccination coverage - United States, 2000-2010.
    MMWR Suppl. 2011 Jan 14;60(1):38-41 PMID: 21430618
  26. Chronic obstructive pulmonary disease phenotypes: the future of COPD.
    Am J Respir Crit Care Med. 2010 Sep 1;182(5):598-604 PMID: 20522794
  27. The costs of treating COPD in the United States.
    Chest. 2001 Feb;119(2):344-52 PMID: 11171708
  28. COPD exacerbations .1: Epidemiology.
    Thorax. 2006 Feb;61(2):164-8 PMID: 16443707
  29. Comorbidity measures for use with administrative data.
    Med Care. 1998 Jan;36(1):8-27 PMID: 9431328
Article Info
Journal
Respiratory research
Abbr.
Respir Res
ISSN
1465-993X
Published
2014-04-10
Epub
2014-00-10
Pages
40
Language
English
Region
England
NLM ID
101090633
PMCID
PMC3997196
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]